AI-driven medical device forum brings global industry leaders

Industrial experts discuss how Chinese medical manufacturing companies can better serve domestic needs while expanding into global markets. [Photo/WeChat account: xinwu_wx]

A medical device-focused forum on artificial intelligence-enabled pharmaceutical and medical technology development was held in Wuxi on May 7 as part of the 2026 Taihu Bay Future Healthcare Conference.

The forum brought together leading enterprises and investment institutions across the healthcare value chain, building an efficient platform for collaboration and connection. It aimed to strengthen links between technology innovation, production capacity, and overseas market channels.

More than 30 companies and academic representatives attended the event, including Becton Dickinson, Boston Scientific, IQVIA, Siemens Healthineers, Medtronic, and C-Bridge Capital, among others.

The event focused on key industry topics such as the outlook of China's medical device market and the global expansion strategies of medical enterprises.

During a roundtable discussion, participants engaged in in-depth dialogue on how Chinese medical manufacturing companies can better serve domestic needs while expanding into global markets.

Speakers shared their practical experiences and insights from perspectives including technological innovation, localized services, cross-border cooperation, and international compliance.

As a major hub for the biopharmaceutical industry, Wuxi National Hi-Tech District (WND) has seen its biomedical industry scale surpass 100 billion yuan ($14.69 billion), accounting for nearly half of Wuxi's total output in the sector. The district ranks 18th in China's national biopharmaceutical industrial parks.

WND has built a coordinated industrial ecosystem covering innovative drugs, CDMO/CMO services, medical devices and in-vitro diagnostics, smart healthcare, and special foods.

It is home to globally recognized enterprises such as AstraZeneca, GE Healthcare, and Danone Nutricia, along with more than 850 high-quality companies including Dizal Pharma.